LIF and COVID-19: Factor D, upregulated by COVID-19 and involved in the alternative pathway, is correlated with markers of endothelial cell injury (e.g., angiotensin 2) and coagulation (e.g., vWF), possibly contributing to the association between COVID-19 and coagulopathy (21).